INSY
Northern Trust’s Insys Therapeutics, Inc. INSY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-364,716
| Closed | -$1.69M | – | 4322 |
|
2019
Q1 | $1.69M | Buy |
364,716
+5,019
| +1% | +$23.2K | ﹤0.01% | 3182 |
|
2018
Q4 | $1.26M | Sell |
359,697
-14,929
| -4% | -$52.3K | ﹤0.01% | 3281 |
|
2018
Q3 | $3.78M | Buy |
374,626
+26,292
| +8% | +$265K | ﹤0.01% | 2861 |
|
2018
Q2 | $2.52M | Buy |
348,334
+32,009
| +10% | +$232K | ﹤0.01% | 3086 |
|
2018
Q1 | $1.91M | Buy |
316,325
+4,098
| +1% | +$24.8K | ﹤0.01% | 3121 |
|
2017
Q4 | $3M | Sell |
312,227
-984
| -0.3% | -$9.46K | ﹤0.01% | 2895 |
|
2017
Q3 | $2.78M | Sell |
313,211
-1,614
| -0.5% | -$14.3K | ﹤0.01% | 2986 |
|
2017
Q2 | $3.98M | Buy |
314,825
+9,906
| +3% | +$125K | ﹤0.01% | 2759 |
|
2017
Q1 | $3.21M | Buy |
304,919
+2,133
| +0.7% | +$22.4K | ﹤0.01% | 2830 |
|
2016
Q4 | $2.79M | Buy |
302,786
+10,067
| +3% | +$92.6K | ﹤0.01% | 2906 |
|
2016
Q3 | $3.45M | Sell |
292,719
-5,953
| -2% | -$70.2K | ﹤0.01% | 2773 |
|
2016
Q2 | $3.87M | Buy |
298,672
+14,574
| +5% | +$189K | ﹤0.01% | 2636 |
|
2016
Q1 | $4.54M | Buy |
284,098
+6,061
| +2% | +$96.9K | ﹤0.01% | 2469 |
|
2015
Q4 | $7.96M | Buy |
278,037
+8,150
| +3% | +$233K | ﹤0.01% | 2168 |
|
2015
Q3 | $7.68M | Buy |
269,887
+36,947
| +16% | +$1.05M | ﹤0.01% | 2168 |
|
2015
Q2 | $8.37M | Buy |
232,940
+122,854
| +112% | +$4.41M | ﹤0.01% | 2179 |
|
2015
Q1 | $6.4M | Buy |
110,086
+712
| +0.7% | +$41.4K | ﹤0.01% | 2351 |
|
2014
Q4 | $4.61M | Sell |
109,374
-2,156
| -2% | -$90.9K | ﹤0.01% | 2563 |
|
2014
Q3 | $4.33M | Buy |
111,530
+20,273
| +22% | +$786K | ﹤0.01% | 2594 |
|
2014
Q2 | $2.85M | Buy |
91,257
+20,666
| +29% | +$645K | ﹤0.01% | 2876 |
|
2014
Q1 | $2.92M | Buy |
70,591
+1,319
| +2% | +$54.6K | ﹤0.01% | 2905 |
|
2013
Q4 | $2.68M | Buy |
69,272
+1,047
| +2% | +$40.5K | ﹤0.01% | 2975 |
|
2013
Q3 | $2.39M | Buy |
68,225
+48,679
| +249% | +$1.7M | ﹤0.01% | 2996 |
|
2013
Q2 | $271K | Buy |
+19,546
| New | +$271K | ﹤0.01% | 3584 |
|